Results 111 to 120 of about 1,313,218 (345)
Historiography after Revisionism. Remarks on Pomian’s Idea of Writing History [PDF]
, 2017 Krzysztof Pomian’s works on history are one of the most interesting theoretical achievements of contemporary humanities. Being one of the prominent revisionists, Pomian took part in an important period of Polish history ...
Leszczyński, Marcin
core
The Image of Disease in Religious, Medical–Astrological and Social Discourses: Old Polish Literature as an Example of Early Modern European Mentality [PDF]
, 2020 Małgorzata Krzysztofik
openalex +1 more source
Design, compilation and applications of an English-Polish-Belarusian Parallel Literary Corpus [PDF]
, 2021 Angelika Peljak-Łapińska
openalex +1 more source
Molecular Oncology, EarlyView.Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Вопросы ономастикиThe article examines the anthroponyms and toponyms found on gravestone inscriptions at cemeteries in the areas of concentrated settlement of national minorities in northern Bosnia and Herzegovina — namely, Ukrainians, Poles, Czechs, and Italians.
Gleb Petrovich Pilipenko +1 more
doaj +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
Molecular Oncology, EarlyView.This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Molecular Oncology, EarlyView.Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
Molecular Oncology, EarlyView.The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source